DXCM
Price
$70.63
Change
+$0.30 (+0.43%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
27.58B
3 days until earnings call
Intraday Buy/Sell Signals
PODD
Price
$325.95
Change
+$5.04 (+1.57%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
22.59B
10 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

DXCM vs PODD

Header iconDXCM vs PODD Comparison
Open Charts DXCM vs PODDBanner chart's image
DexCom
Price$70.63
Change+$0.30 (+0.43%)
Volume$55.7K
Capitalization27.58B
Insulet
Price$325.95
Change+$5.04 (+1.57%)
Volume$5.52K
Capitalization22.59B
DXCM vs PODD Comparison Chart in %
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. PODD commentary
Oct 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and PODD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 28, 2025
Stock price -- (DXCM: $70.33 vs. PODD: $320.91)
Brand notoriety: DXCM and PODD are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: DXCM: 62% vs. PODD: 52%
Market capitalization -- DXCM: $27.58B vs. PODD: $22.59B
DXCM [@Medical/Nursing Services] is valued at $27.58B. PODD’s [@Medical/Nursing Services] market capitalization is $22.59B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $220.78B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whilePODD’s FA Score has 1 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • PODD’s FA Score: 1 green, 4 red.
According to our system of comparison, PODD is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 4 TA indicator(s) are bullish while PODD’s TA Score has 4 bullish TA indicator(s).

  • DXCM’s TA Score: 4 bullish, 5 bearish.
  • PODD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DXCM is a better buy in the short-term than PODD.

Price Growth

DXCM (@Medical/Nursing Services) experienced а +5.60% price change this week, while PODD (@Medical/Nursing Services) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.08%. For the same industry, the average monthly price growth was +4.17%, and the average quarterly price growth was +16.30%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 30, 2025.

PODD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($27.6B) has a higher market cap than PODD($22.6B). PODD has higher P/E ratio than DXCM: PODD (97.84) vs DXCM (49.53). PODD YTD gains are higher at: 22.921 vs. DXCM (-9.567). DXCM has higher annual earnings (EBITDA): 1.04B vs. PODD (407M). DXCM has more cash in the bank: 2.93B vs. PODD (1.12B). PODD has less debt than DXCM: PODD (1.4B) vs DXCM (2.58B). DXCM has higher revenues than PODD: DXCM (4.3B) vs PODD (2.36B).
DXCMPODDDXCM / PODD
Capitalization27.6B22.6B122%
EBITDA1.04B407M255%
Gain YTD-9.56722.921-42%
P/E Ratio49.5397.8451%
Revenue4.3B2.36B182%
Total Cash2.93B1.12B261%
Total Debt2.58B1.4B184%
FUNDAMENTALS RATINGS
DXCM vs PODD: Fundamental Ratings
DXCM
PODD
OUTLOOK RATING
1..100
3615
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
4147
PRICE GROWTH RATING
1..100
6247
P/E GROWTH RATING
1..100
327
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (78) in the Medical Specialties industry is in the same range as PODD (89). This means that DXCM’s stock grew similarly to PODD’s over the last 12 months.

PODD's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as DXCM (100). This means that PODD’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's SMR Rating (41) in the Medical Specialties industry is in the same range as PODD (47). This means that DXCM’s stock grew similarly to PODD’s over the last 12 months.

PODD's Price Growth Rating (47) in the Medical Specialties industry is in the same range as DXCM (62). This means that PODD’s stock grew similarly to DXCM’s over the last 12 months.

PODD's P/E Growth Rating (7) in the Medical Specialties industry is in the same range as DXCM (32). This means that PODD’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMPODD
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
67%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 6 days ago
67%
Declines
ODDS (%)
Bearish Trend 21 days ago
71%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TJAN27.160.09
+0.33%
Innovator Equity Defined Protection ETF - 2 Yr to January 2027
IBND32.120.05
+0.16%
SPDR® Blmbg Intl Corp Bd ETF
AMJB29.34N/A
N/A
Alerian MLP Index ETN
HCOW24.20-0.04
-0.17%
Amplify COWS Covered Call ETF
JPC8.08-0.02
-0.25%
Nuveen Preferred & Income Opportunities Fund